Related Experiment Video

Updated: Jul 9, 2025

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

28.1K

Expression of oncogenic HRAS G12V causes defects in control of cell size in NIH 3T3 cells

Jerry T DeWitt1, Michael V Sharma1, Douglas R Kellogg1

  • 1Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, Santa Cruz, California, United States.

Micropublication Biology
|November 29, 2023
PubMed

Insights

Oncogenic HRAS (Harvey rat sarcoma viral oncogene homolog) G12V expression directly causes cell size defects in NIH 3T3 cells. This finding suggests cancer cell size abnormalities stem from primary oncogenic drivers, not accumulated mutations.

Area of Science:

  • Cell biology
  • Cancer research
  • Molecular oncology

Background:

  • Cell size control is crucial and its defects are linked to cancer.
  • The origins of cancer-related cell size defects are unclear, with debate on whether they arise from primary oncogenic signals or secondary mutations.

Purpose of the Study:

  • To investigate whether oncogenic HRAS expression is sufficient to induce cell size defects.
  • To determine if cell size defects in cancer are a direct result of primary oncogenic drivers.

Main Methods:

  • Expression of oncogenic HRAS G12V in NIH 3T3 cells.
  • Analysis of cell size control mechanisms.

Main Results:

  • Expression of oncogenic HRAS G12V was sufficient to cause significant cell size defects in NIH 3T3 cells.
  • This indicates a direct link between HRAS oncogene activation and aberrant cell growth.

Conclusions:

  • Cell size defects observed in cancer are likely a direct consequence of primary oncogenic drivers, such as HRAS.
  • This study provides evidence against cell size defects being solely a secondary consequence of accumulated mutations during cancer evolution.

More Related Videos

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.6K
Inducible and Reversible Dominant-negative DN Protein Inhibition08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.4K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K